Commercial analytics and Forecasting underpins strategic decision-making and business planning in pharma companies. Its application ranges from health economics, and opportunity and market assessment (pre-clinical stage), to strategic forecasting (clinical stage), to in-line product forecasting, pricing analytics and market access assessments (launch and in-line product phase). However, companies often struggle to streamline and optimize globally driven business planning processes. Some of the key challenges include complex and multi-sourced data-based market assessments, lack of insights in strategic forecasting and unoptimized planning processes.
At WNS, we help 10+ pharma companies with specialized commercial assessment projects, new and advanced methods of forecasting and dedicated support for business planning. Our comprehensive pharma forecasting capabilities enable clients to assess and optimize the commercial value of assets by combining distinctive and diverse data (both directional and evidence-based), and capturing actionable insights through advanced modeling.
WNS Forecasto, our customizable cloud-based pharma forecasting platform, drives effective collaboration, compliance and knowledge management with efficient construction, collation and consolidation of forecasts. It supports forecasting across the product life cycle – pre-launch, launch and in-line – and underpins key processes such as strategic plan, long-range forecasting and budgeting.